What is Encore Vision?
Established in 2003, Encore Vision, Inc. operates as a specialized provider of high-quality eyewear products and accessories. With an expansive inventory exceeding 50,000 frames and a sophisticated full-service digital lab, the company bridges the gap between manufacturing efficiency and clinical precision. Their core competency lies in advanced lens processing and specialty edging, which allows them to meet the rigorous demands of modern optometry practices. By prioritizing both style and value, Encore Vision has carved out a significant market share, positioning itself as a reliable partner for both independent practitioners and large-scale optical retailers.
How much funding has Encore Vision raised?
Encore Vision has raised a total of $11.9M across 6 funding rounds:
Private Equity
$1.7M
Series B
$949K
Series C
$4.5M
Series A
$4.5M
Debt
$150K
Debt
$138K
Private Equity (2014): $1.7M, investors not publicly disclosed
Series B (2015): $949K, investors not publicly disclosed
Series C (2015): $4.5M supported by Steelhead Capital Management
Series A (2016): $4.5M featuring Steelhead Capital Management, Cowtown Angels, and Bios Partners
Debt (2020): $150K backed by PPP
Debt (2021): $138K with participation from PPP
Key Investors in Encore Vision
Steelhead Capital Management
Steelhead Capital Management is a Fort Worth-based family office that focuses on high-growth opportunities, providing tailored investment solutions for high-net-worth individuals and families.
Cowtown Angels
Cowtown Angels is an angel investment network that provides early-stage capital and mentorship to promising startups, fostering innovation within the regional business ecosystem.
Bios Partners
Bios Partners is a venture capital firm specializing in the healthcare and life sciences sectors, focusing on companies that demonstrate significant potential for clinical and commercial impact.
What's next for Encore Vision?
With the recent influx of capital, Encore Vision is well-positioned to accelerate its digital transformation and expand its laboratory capacity. The strategic focus will likely shift toward optimizing supply chain logistics and integrating next-generation lens processing technologies to maintain a competitive edge. As the company moves beyond its current lifecycle stage, the emphasis will remain on scaling its service infrastructure to accommodate increasing demand for high-quality, cost-effective optical solutions. Future growth will be driven by the company's ability to leverage its existing partnerships while exploring new avenues for market penetration in the broader healthcare technology landscape.
See full Encore Vision company page
